EHR-based Screening and Intervention for Intimate Partner Violence
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 19,655
- 试验地点
- 2
- 主要终点
- Screening completed (Yes/No)
研究概览
简要总结
Intimate partner violence (IPV) against women in the US is a serious public health problem and a human rights issue. Our research team has developed confidential screening tools using exam-room computer for intimate partner violence to be used in primary care.
详细描述
The objective of this study was to develop and evaluate an integrated suite of electronic health record (EHR) tools that automates "best practices" from Northern California Kaiser Permanente for screening and intervention for IPV identified within clinical settings. The goal of the intervention goes beyond mere screening of patients for IPV and includes tools for assessment of IPV risk, for documentation of IPV care, and support for a warm hand-off during the primary care visit to a national IPV hotline resource. Importantly, the study includes work to keep notes documenting IPV and billing for IPV care confidential, segmenting this care in a secure segment of the electronic health record.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Sequential
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 49 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Being an Medical University of South Carolina patient at primary care clinics (family medicine)
- •Women 18-49 years of age inclusive
- •Reported yes to wanting to be contacted for a follow-up research study
- •English-speaking
排除标准
- •No exclusion criteria
研究组 & 干预措施
Sequence 2
5 clinics.
干预措施: Assessment and referral (Other)
Sequence 1
5 clinics. In stepped wedge design study, this was the sequence with shortest control (run-in) period.
All sequences have a run-in period and intervention period. In control period participants were screened using existing nurse-led oral screening, in intervention period both - nurse-led and our new confidential screen were used at the same time.
干预措施: Screening for intimate partner violence (Diagnostic Test)
Sequence 1
5 clinics. In stepped wedge design study, this was the sequence with shortest control (run-in) period.
All sequences have a run-in period and intervention period. In control period participants were screened using existing nurse-led oral screening, in intervention period both - nurse-led and our new confidential screen were used at the same time.
干预措施: Assessment and referral (Other)
Sequence 2
5 clinics.
干预措施: Screening for intimate partner violence (Diagnostic Test)
Sequence 3
5 clinics. This was the sequence with longest control (run-in) period.
干预措施: Screening for intimate partner violence (Diagnostic Test)
Sequence 3
5 clinics. This was the sequence with longest control (run-in) period.
干预措施: Assessment and referral (Other)
结局指标
主要结局
Screening completed (Yes/No)
时间窗: 29 months
Whether the assigned screening was completed during patient visit
IPV positive (Yes/No)
时间窗: 29 months
Depending on patient's answers to screening questions, they are flagged as either IPV positive or negative
次要结局
- Severity of risk(29 months)
- Physician compliance with IPV management tools(29 months)
研究者
Leslie Lenert
Professor-Faculty
Medical University of South Carolina